Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Google is rolling out out a new feature for Gemini's Canvas, the free interactive workspace inside the AI chatbot's app, meant for students and employees who need to create presentations. Gemini is ...

If you’re new to generators, you’ve probably found yourself asking: What’s an inverter generator? It’s a term that pops up as soon as you start doing research. Inverter generators are more expensive ...

With powerful video generation tools now in the hands of more people than ever, let's take a look at how they work. MIT Technology Review Explains: Let our writers untangle the complex, messy world of ...

It was January 2023. Elon Musk owned Twitter, but it wasn’t yet called X. ChatGPT had been released barely six weeks earlier. Absci CEO Sean McClain — tall, with short, gelled hair and a beard, the ...

The Codeigniter 4 Route Generator is a PHP package designed to automate the generation of routes for CodeIgniter 4 applications. It scans your controller classes, extracts route information from ...

Make your chats more interesting with Image Playground in the Messages app, which can create an AI version of existing photos or generate new ones from your prompts. I've written for various ...

The tech giant is among the many companies building technology that could remake Hollywood — or help spread disinformation. This video’s A.I. prompt: “The camera is behind a man. The man is shirtless, ...

Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis. The wide-ranging deal, worth up to $1 billion, ...

Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop protein therapeutics across multiple indications. The companies did not disclose ...